Sarepta Therapeutics Q1 2026 Earnings: Big Beat, But Stock Still Falls
Sarepta reported strong Q1 2026 earnings, with revenue of $730.8M, but shares fell as Elevidys sales dropped 46% due to label restrictions.
Sarepta reported strong Q1 2026 earnings, with revenue of $730.8M, but shares fell as Elevidys sales dropped 46% due to label restrictions.
Snap reported $1.53B in Q1 revenue with an increase in users, but ad sales were hit by the Iran conflict, and the company ended its AI partnership. It is now cutting costs.
IONQ revenue surged 755% and beat expectations, but higher losses and negative cash flow worried investors, so stock fell after hours.
AppLovin beat Q1 earnings, raised outlook, and grew revenue with strong AI-driven ads, boosting stock.
DoorDash beat profit expectations, raised its outlook, and demand remains strong despite higher fuel cost support for drivers.
Beyond Meat missed earnings, stock fell 9%. Sales weak, losses high, but costs improved. Demand for plant meat still low.